June 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJuly 16, 2026
According to market projections, the bacterial cell culture sector is expected to grow from USD 3.91 billion in 2026 to USD 7.00 billion by 2035, reflecting a CAGR of 6.7%. The bacterial cell culture market is growing significantly due to the growing use of developing various bacterial-based products & research. North America is leading due to ...
July 16, 2026
According to forecasts, the global TD vaccine market will grow from USD 6.89 billion in 2026 to USD 11.29 billion by 2035, with an expected CAGR of 5.64%. Increasing global health programs and the development of combination vaccines are fueling demand for the Td vaccine around the globe. However, the Asia Pacific dominated market due to high birth ...
July 16, 2026
Market insights predict, the biologics safety testing industry is expected to grow from USD 5.20 billion in 2026 to USD 16.45 billion by 2035, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activities drive the market. North America dominated the global market owing to the presence of key players a...
July 16, 2026
Based on market forecasts, the microcarriers sector will expand from USD 2.19 billion in 2026 to USD 5.81 billion by 2035, experiencing a CAGR of 11.48%.The microcarriers market is growing due to they are broadly applied in medical regeneration, including use in cell expansion/bioreactors, scaffold combinations, micro-tissue and disease models, car...
July 16, 2026
Projections indicate that, the global generative AI in drug discovery market will increase from USD 405.90 million in 2026 to USD 3593.80 million by 2035, experiencing a CAGR of 27.42% over the next 10 years. The generative AI in drug discovery market is growing rapidly due to technological advancements and rising government initiatives to develop ...
July 16, 2026
Projections indicate that, the global protein expression technology market will increase from USD 3.26 billion in 2026 to USD 5.58 billion by 2035, experiencing a CAGR of 6.94% over the next 10 years. The protein expression technology market is expanding due to the increasing use of biopharmaceuticals as well as rising advancements in therapeutic a...
July 16, 2026
Market insights predict the global gene therapy industry will increase from USD 13.68 billion in 2026 to USD 70.59 billion by 2035, achieving a CAGR of 20%. The gene therapy market is growing rapidly due to the growing demand for precision medicine. North America’s dominance is attributed to the rising focus on genomics & multi-omics....
July 16, 2026
Based on market forecasts, the western blotting sector will expand from USD 2.13 billion in 2025 to USD 3.84 billion by 2035, experiencing a CAGR of 6.05%. The increasing prevalence of chronic disorders and technological advancements drive the market. North America dominated the global market owing to the presence of key players and increasing rese...
July 16, 2026
According to forecasts, the global pain management devices market will grow from USD 7.68 billion in 2026 to USD 20.92 billion by 2035, with an expected CAGR of 9.54%. The rising prevalence of acute and chronic pain and the need for personalized treatment boost the market. Favorable government policies and robust healthcare infrastructure contribut...
July 16, 2026
According to our projections, the global lung cancer trial market, valued at USD 4.34 billion in 2025, is anticipated to reach USD 9.76 billion by 2035, growing at a CAGR of 8.45% over the next decade. The lung cancer trial market is growing due to it helps inform the lung cancer patient community related to novel medications and advances in types ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
